CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Network Study Title CIRB
NWU2015-06-01 CLO-Northwestern University Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention Cancer Prevention and Control CIRB
NWU2015-06-02 CLO-Northwestern University Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Renal Transplantation in Adults: A Prospective, Single-Arm, Multi-Center Clinical Trial Cancer Prevention and Control CIRB
NWU2015-06-03 CLO-Northwestern University Statin Therapy to Reduce Disease Progression from Liver Cirrhosis to Cancer Cancer Prevention and Control CIRB
NWU2015-06-04 CLO-Northwestern University Phase IIB trial of neoadjuvant oral tamoxifen versus transdermal 4-hydroxytamoxifen in women with DCIS of the breast Cancer Prevention and Control CIRB
NWU2016-08-02 CLO-Northwestern University A Phase I Single-Arm, Multicenter Pilot Study Aimed at Validating Gamma-OHPdG as a Biomarker and Testing the Effects of Polyphenon E® on its Levels in Patients with Cirrhosis Cancer Prevention and Control CIRB
NWU2017-09-01 CLO-Northwestern University Phase I trial of endoxifen gel versus placebo gel in women undergoing breast surgery Cancer Prevention and Control CIRB
NWU21-08-01 CLO-Northwestern University Phase II Trial of Oral Iloprost for the Precision Chemoprevention of Lung Cancer Cancer Prevention and Control CIRB
PACCT-1 ECOG Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial Adult CIRB - Late Phase Emphasis
PBTC-049 PBTC A Phase I study of Savolitinib in Recurrent, Progressive or Refractory Medulloblastoma, High-Grade Glioma, Diffuse Intrinsic Pontine Glioma and CNS tumors harboring MET aberrations Pediatric CIRB
PBTC-051 PBTC Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects with Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma Pediatric CIRB